Related Experiment Video
Updated: Jun 25, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?
Clement Tan1,2, Mark Daniel Higgins1,3, Vaikunthan Thanabalasingam1
1Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia.
Insights
Cerebral protection devices (CPDs) mitigate stroke risks during cardiac procedures. This review covers their clinical importance, evidence, and future in catheterization labs.
Area of Science:
- Cardiology
- Neurology
- Medical Devices
Background:
- Stroke is a significant complication of cardiac percutaneous transcatheter procedures.
- Silent strokes, even without clinical symptoms, raise concerns for cognitive decline and mortality.
- Cerebral protection devices (CPDs) are designed to reduce thromboembolic events during these interventions.
Purpose of the Study:
- To review the clinical significance and stroke rates associated with CPDs.
- To present updated evidence on various CPDs and their effectiveness.
- To discuss the future role and cost-benefits of CPDs in cardiac catheterization.
Main Methods:
- Literature review of existing studies on cerebral protection devices.
- Analysis of clinical data regarding stroke rates and CPD efficacy.
- Discussion of current evidence, device variations, and procedural applications.
Main Results:
- CPDs, utilizing filter or deflector mechanisms, aim to neutralize stroke risk.
- Evidence varies among different CPDs and transcatheter procedures.
- CPDs enable high-risk patients to undergo procedures previously contraindicated.
Conclusions:
- CPDs play a crucial role in managing stroke risk during cardiac interventions.
- Continued research and development are essential for optimizing CPD use.
- The adoption of CPDs expands treatment options for patients with high thromboembolic risk.
Abstract:
Stroke is a devastating complication of cardiovascular interventions. Intraprocedural stroke is a well-documented and feared risk of cardiac percutaneous transcatheter procedures. If clinically significant strokes are absent, silent strokes remain the next in line to pose large concerns related to future cognitive decline, stroke risk, and overall increased morbidity and mortality. Cerebral protection devices (CPD) developed overtime aim to neutralize this risk through either a capture-based filter or a deflector mechanism. Many CPDs exist currently, each one unique, with varying degrees of evidence. The adoption of CPDs has allowed cardiac percutaneous transcatheter procedures to be carried out in patients with high thromboembolic risks who may have historically been discommended. Though skewed towards certain devices and transcatheter procedures, a large body of evidence is still present across other devices and procedures. This review will discuss clinical importance and respective stroke rates, updated evidence surrounding CPDs, differing opinions across types of CPDs, cost benefits, and what lies ahead for CPDs within the realm of procedures undertaken in cardiac catheterization laboratories.
More Related Videos
10:46Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Cardiac Catheterization I: Pre-Procedure Overview
Cardiac Catheterization II: Right Heart Catheterization
Cardiac Catheterization III: Left Heart Catheterization
Cardiac Catheterization IV: Nursing Management
Cardiopulmonary Resuscitation III: AED Use